These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15052817

  • 1. [Collagen diseases and rheumatic diseases].
    Takeuchi T, Amano K, Tsuzake K, Kameda H, Abe T.
    Nihon Naika Gakkai Zasshi; 2004 Mar 10; 93(3):538-44. PubMed ID: 15052817
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A.
    Ann Rheum Dis; 2009 Dec 10; 68(12):1856-62. PubMed ID: 19126559
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis.
    Cobo Ibáñez T, Yehia Tayel M, Balsa Criado A, Hernández Sanz A, Martín Mola E.
    Rheumatology (Oxford); 2005 Nov 10; 44(11):1467-8. PubMed ID: 16174647
    [No Abstract] [Full Text] [Related]

  • 4. Infliximab-induced lupus or rheumatoid arthritis (RA) overlapping with systemic lupus erythematosus (SLE) unmasked by infliximab.
    Novak S, Cikes N.
    Clin Exp Rheumatol; 2004 Nov 10; 22(2):268. PubMed ID: 15083903
    [No Abstract] [Full Text] [Related]

  • 5. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
    Hochberg MC, Tracy JK, Flores RH.
    Ann Rheum Dis; 2001 Nov 10; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
    [No Abstract] [Full Text] [Related]

  • 6. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May 10; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [TNF targetting therapy for rheumatoid arthritis].
    Takeuchi T.
    Nihon Naika Gakkai Zasshi; 2006 Sep 10; 95(9):1787-94. PubMed ID: 17037316
    [No Abstract] [Full Text] [Related]

  • 10. Progress in the treatment of rheumatoid arthritis.
    Pisetsky DS, St Clair EW.
    JAMA; 2001 Dec 12; 286(22):2787-90. PubMed ID: 11735734
    [No Abstract] [Full Text] [Related]

  • 11. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
    Geborek P, Crnkic M, Petersson IF, Saxne T, South Swedish Arthritis Treatment Group.
    Ann Rheum Dis; 2002 Sep 12; 61(9):793-8. PubMed ID: 12176803
    [Abstract] [Full Text] [Related]

  • 12. [New ways in the management of rheumatoid arthritis in Hungary].
    Gergely P, Poór G.
    Lege Artis Med; 2007 Oct 12; 17(10):657-64. PubMed ID: 19227595
    [Abstract] [Full Text] [Related]

  • 13. Newer approaches to the treatment of rheumatoid arthritis.
    Finesilver AG.
    WMJ; 2003 Oct 12; 102(7):34-7. PubMed ID: 14711022
    [Abstract] [Full Text] [Related]

  • 14. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T.
    Medsurg Nurs; 2004 Dec 12; 13(6):420-8. PubMed ID: 15714747
    [No Abstract] [Full Text] [Related]

  • 15. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
    Boers M, COBRA Study Group. Combinatietherapie Bij Reumatoide Artritis.
    Arthritis Rheum; 2001 Nov 12; 44(11):2703-4. PubMed ID: 11710727
    [No Abstract] [Full Text] [Related]

  • 16. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F, Koehm M, Burkhardt H.
    Curr Opin Rheumatol; 2011 May 12; 23(3):282-7. PubMed ID: 21427581
    [Abstract] [Full Text] [Related]

  • 17. Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray.
    Barthel HR.
    Arthritis Rheum; 2001 Oct 12; 45(5):472. PubMed ID: 11642648
    [No Abstract] [Full Text] [Related]

  • 18. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr 12; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 19. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM.
    Ann Intern Med; 2001 Apr 17; 134(8):695-706. PubMed ID: 11304108
    [Abstract] [Full Text] [Related]

  • 20. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
    Liao TL, Chen YM, Liu HJ, Chen DY.
    BMJ Open; 2017 Jan 05; 7(1):e014032. PubMed ID: 28057661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.